Medfinder
Back to blog

Updated: January 3, 2026

Alternatives to Onyda XR If You Can't Fill Your Prescription

Author

Peter Daggett

Peter Daggett

Multiple medication bottles in a branching path suggesting alternatives

Can't find Onyda XR in stock? Here are the best non-stimulant and stimulant ADHD medication alternatives your doctor may consider as substitutes.

If your pharmacy can't fill Onyda XR and you've exhausted your options, or if the cost is a barrier, your child's doctor may consider an alternative. The right alternative depends on your child's age, medical history, what treatments they've tried before, and whether they need a liquid formulation.

This guide covers the most common alternatives to Onyda XR in 2026, organized from closest in class to broader options.

What Makes Onyda XR Unique?

Before looking at alternatives, it's worth understanding what makes Onyda XR special: it's the only extended-release liquid (oral suspension) non-stimulant ADHD medication approved in the United States. If a liquid formulation is medically necessary for your child — for example, because they can't swallow pills — direct substitution with another medication may be harder.

Closest Alternative: Kapvay (Clonidine ER Tablets)

Kapvay is the brand name for clonidine hydrochloride extended-release tablets — the same active ingredient as Onyda XR, but in tablet form. Generic versions of Kapvay are widely available and typically much less expensive.

Important caution: Onyda XR and Kapvay are NOT interchangeable on a milligram-per-milligram basis. The prescribing information explicitly states they have different pharmacokinetic profiles. Your doctor will need to carefully calculate the appropriate dose if switching between these two formulations.

Dosing: Twice daily (Kapvay tablets vs. once daily for Onyda XR)

Advantage: Generic widely available, typically much lower cost

Disadvantage: Tablet form only — not suitable if your child needs a liquid

Intuniv (Guanfacine XR) — Another Alpha-2 Agonist

Intuniv (guanfacine extended-release) is a once-daily, non-stimulant ADHD medication in the same drug class as Onyda XR — alpha-2 adrenergic agonists. It's approved for children and adolescents aged 6 to 17, and generic guanfacine XR is widely available.

Dosing: 1–4 mg once daily, typically in the morning

Advantage: Once daily, generic available, well-established safety record

Disadvantage: Tablet only, morning dosing (vs. bedtime for Onyda XR)

Strattera (Atomoxetine) — A Non-Stimulant SNRI

Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor (SNRI) approved for ADHD in children aged 6 and older, adolescents, and adults. Generic atomoxetine is available, which significantly reduces cost.

Dosing: Once or twice daily capsules; doses based on body weight

Advantage: Approved for adults too, works well for anxious patients, generic available

Disadvantage: Takes 4–8 weeks to reach full effect; carries a boxed warning for suicidal ideation in pediatric patients

Qelbree (Viloxazine XR) — A Newer Non-Stimulant

Qelbree (viloxazine XR) is a once-daily, extended-release non-stimulant ADHD medication approved for children aged 6 to 17. Unlike Onyda XR, it's typically taken in the morning. It's a newer option that has shown good efficacy for inattention symptoms.

Dosing: 100–400 mg once daily in the morning

Advantage: Not a controlled substance, no generic (but no stimulant concerns)

Disadvantage: Brand only, expensive without insurance, daytime sedation possible

Stimulant Medications — If Non-Stimulants Aren't Working

If your child was prescribed Onyda XR as monotherapy and needs a switch, stimulant medications remain the most commonly prescribed first-line treatment for ADHD. These include methylphenidate-based drugs (Ritalin, Concerta, Quillivant XR liquid) and amphetamine-based drugs (Adderall, Vyvanse). However, stimulants are Schedule II controlled substances and have different risk profiles and prescription requirements.

What About Liquid Stimulant Options?

If a liquid formulation is essential for your child, Quillivant XR (methylphenidate extended-release oral suspension) and Quillichew ER (methylphenidate chewable tablets) are alternatives to consider. Both are made by Tris Pharma and are Schedule II controlled substances. Dyanavel XR (amphetamine oral suspension) is another liquid stimulant option.

Always Talk to Your Child's Doctor Before Switching

Every alternative has trade-offs. Some require more frequent dosing. Some carry stricter controlled-substance rules. Some take weeks to show full effect. Your child's pediatrician or psychiatrist is best positioned to recommend the right switch based on your child's full medical history.

Before switching, also make sure you've exhausted options for finding Onyda XR. See our post: How to Find Onyda XR in Stock Near You.

And if you want help locating any of these medications at a pharmacy near you, medfinder covers all medications — not just Onyda XR.

Frequently Asked Questions

The closest substitute is Kapvay (clonidine ER tablets) or its generic equivalent, which contains the same active ingredient. However, they are not interchangeable on a milligram-per-milligram basis due to different pharmacokinetic profiles. Your doctor must calculate the correct dose if switching.

Yes. Intuniv (guanfacine XR) is in the same drug class as Onyda XR — alpha-2 adrenergic agonists — and is a once-daily, non-stimulant ADHD medication. Generic guanfacine XR is widely available. It's approved for ages 6–17. It is typically taken in the morning rather than at bedtime.

Strattera (atomoxetine) is an alternative non-stimulant ADHD medication for children 6 and older. It works through a different mechanism (SNRI rather than alpha-2 agonist) and takes 4–8 weeks to reach full effect. It carries a boxed warning for suicidal ideation in pediatric patients. Consult your child's doctor before switching.

Yes. Liquid stimulant options include Quillivant XR (methylphenidate extended-release oral suspension) and Dyanavel XR (amphetamine oral suspension), both Schedule II controlled substances. Onyda XR is the only liquid non-stimulant ADHD medication approved in the US as of 2026.

Immediate-release clonidine tablets are not an approved ADHD treatment and require multiple daily doses. The pharmacokinetic profile is very different from Onyda XR. Never substitute without explicit instructions from your doctor, as dosing errors can cause dangerous changes in blood pressure.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Onyda XR also looked for:

30,351 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,351 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?